Optimizing vector production & purification to enhance scalable AAV manufacturing

The rapid growth of the gene therapy field has driven demand for a reliable and scalable adeno-associated viral (AAV) vector manufacturing solution.

This poster describes how upstream production yields can be maximized using the Gibco™ AAV MAX helper-free AAV production system, and downstream recovery and purity can be optimized using the POROS™ CaptureSelect™ AAVX chromatography resin.

Please enter your email to access content Read now